JD.Com Inc (JD) Stock Price Today
Acoramidis shows 18% lower risk of death and hospitalizations versus tafamidis in real-world ATTR-CM study
Acoramidis, a drug for transthyretin amyloid cardiomyopathy (ATTR-CM), was linked to an 18% lower risk of death, hospitalization, and disease progression compared to tafamidis in a large U.S. electronic health record study of 2,684 patients. The stud...
Stellantis unveils six bold concept cars ahead of the Paris Motor Show, showcasing future mobility and design innovation.
Stellantis revealed six concept cars from its iconic brands at an exclusive event before the Paris Motor Show, highlighting its FaSTLAne 2030 strategy focused on innovation, customer experience, and diverse mobility solutions. These concepts, includi...
New version of Freenome's blood test shows improved detection of advanced precancerous colorectal lesions
Freenome announced improved clinical validation results for its updated SimpleScreen™ CRC blood test, showing an 18.2% sensitivity for advanced precancerous lesions (APLs), up from 13.7% in the original test. Sensitivity for high-grade dysplasia APLs...
Latigo Biotherapeutics undervalued with promising pain drug outperforming Vertex's, key Phase 3 trial ahead.
Latigo Biotherapeutics is currently trading below its IPO value despite showing strong potential with its drug onzotrigine, which has demonstrated better efficacy in acute pain compared to Vertex's Journavx. The company benefits from leveraging Verte...
Eaton Vance ETW fund offers 8.24% yield with global equity exposure and a deep NAV discount.
The Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund (ETW) provides investors with diversified exposure to U.S. and global equities through an index call-write strategy. Currently trading at a 10.88% discount to NAV, ETW offers an attracti...
VistaShares Target 15 Berkshire Select Income ETF (OMAH) remains a Hold with high payout but limited growth potential.
The VistaShares Target 15 Berkshire Select Income ETF (OMAH) is rated as a Hold due to its defensive nature and high payout supported by an aggressive option overwrite strategy. However, this approach causes gradual net asset value erosion, especiall...
3 dividend ETFs to buy at 40 and hold through retirement for steady income and growth
Three dividend ETFs—Schwab U.S. Dividend Equity ETF (SCHD), WisdomTree U.S. Quality Dividend Growth Fund (DGRW), and iShares Core High Dividend ETF (HDV)—offer different strategies for investors planning to buy at age 40 and hold until 80. SCHD focus...
Construction starts on BXP's $2B, 46-story tower at 343 Madison Ave, with major tenants signed.
BXP has begun construction on its 46-story, $2 billion tower at 343 Madison Ave, reaching the podium level already. The project secured a $1.2 billion construction loan last month and has signed marquee tenants like insurance giant Starr and law firm...
Most investors lose money by trading too much; patience and holding through ups and downs build wealth, says Michael Moritz.
Michael Moritz, who backed Google and PayPal, explains that most investors fail because they can't resist acting on short-term market moves, which interrupts the compounding growth of investments. He highlights Amazon as an example, noting that its s...
Chewy remains a buy despite valuation dip, driven by strong autoship revenue and raised FY26 guidance.
Chewy is considered a buy as its valuation drops to about 7 times FY27 EBITDA due to cyclical pressures, despite strong fundamentals and brand loyalty. The company's autoship program accounts for 85% of revenue, ensuring steady sales even as discreti...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.